Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07846059 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Mavacamten-Based Practice in Chinese Adults With Obstructive Hypertrophic Cardiomyopathy

Name: Evaluation of Mavacamten-Based Practice in Chinese Adults With Obstructive Hypertrophic Cardiomyopathy — clinical trial record (NCT07846059)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: REMAP-HCM

StatusNot Yet Recruiting

PhaseNot specified

SponsorBristol-Myers Squibb

Started2026-09-30

View on ClinicalTrials.gov ↗

Bristol-Myers Squibb

311 trials monitored

See 15 trials at risk

The study will describe how mavacamten is used in routine care for Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), including use as monotherapy or with other background/concomitant oHCM medications.

Trial Details

NCT Number	NCT07846059
Lead Sponsor	Bristol-Myers Squibb
Conditions	Obstructive Hypertrophic Cardiomyopathy (oHCM)
Enrollment	800 participants
Start Date	2026-09-30
Primary Completion	2027-03-31 (estimated)
Study Completion	2027-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-09-29